Screener
Neuropace, Inc. NPCE CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
| (in thousands) | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Operating lease liabilities | (1,036) | (911) |
| Net cash used in operating activities | (9,803) | (9,568) |
| Cash flows from investing activities | ||
| Acquisition of property and equipment | (242) | (205) |
| Net cash used in investing activities | (242) | (205) |
| Cash flows from financing activities | ||
| Proceeds from issuance of common stock in follow-on offering, net of underwriting discounts and commissions | — | 69,704 |
| Repurchase of common stock from KCK Ltd. | — | (49,546) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Neuropace, Inc.'s capex?
- Neuropace, Inc. (NPCE) reported capex of $125K in Q2 2026.
- How has Neuropace, Inc.'s capex changed year-over-year?
- Neuropace, Inc.'s capex decreased by 25.6% year-over-year, from $168K to $125K.
- What is the long-term trend for Neuropace, Inc.'s capex?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s capex has grown at a -3.6% compound annual growth rate (CAGR), from $384K to $332K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Neuropace, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude